
BiologicalActivity
Antifibroticagent;inhibitsfibrosisbytargetingtheMRTF/SRFgenetranscriptionpathway.SelectivelyinhibitsproliferationofSSc-deriveddermalfibroblastsbutnotthatofnormalfibroblasts.InhibitsexpressionofCTGF,α-SMA,andCOL1A2inSScfibroblastsaswellasinLPAandinTGFβ-stimulatedfibroblasts.Preventsbleomycin-inducedskinthickeningandcollagendepositioninvivo.AlsosuppressesPC-3cellmigrationinscratchwoundassays(IC50=4.2μM).
TechnicalData
M.Wt | 408.88 |
Formula | C23H21ClN2O3 |
Storage | Storeat+4°C |
Purity | ≥98%(HPLC) |
CASNumber | 1443437-74-8 |
PubChemID | 71681561 |
InChIKey | HERLZBNILRVHQN-UHFFFAOYSA-N |
Smiles | O=C(N2CCCC(C(NC3=CC=C(Cl)C=C3)=O)C2)C1=CC=CC(C4=CC=CO4)=C1 |
Thetechnicaldataprovidedaboveisforguidanceonly.ForbatchspecificdatarefertotheCertificateofAnalysis.
AllTocrisproductsareintendedforlaboratoryresearchuseonly.
SolubilityData
Solvent | MaxConc.mg/mL | MaxConc.mM | |
---|---|---|---|
Solubility | |||
DMSO | 20.44 | 50 |
PreparingStockSolutions
Thefollowingdataisbasedontheproductmolecularweight408.88.Batchspecificmolecularweightsmayvaryfrombatchtobatchduetosolventofhydration,whichwillaffectthesolventvolumesrequiredtopreparestocksolutions.
Concentration/SolventVolume/Mass | 1mg | 5mg | 10mg |
---|---|---|---|
1mM | 2.45mL | 12.23mL | 24.46mL |
5mM | 0.49mL | 2.45mL | 4.89mL |
10mM | 0.24mL | 1.22mL | 2.45mL |
50mM | 0.05mL | 0.24mL | 0.49mL |